ANNALS OF ONCOLOGY, vol.26, no.1, pp.245, 2015 (Journal Indexed in SCI)
Article / Letter
Title of Journal :
ANNALS OF ONCOLOGY
This letter criticize the design of ACTS-CC trial; patients received adjuvant oral fluoropyrimidine therapy without oxaliplatin. Authors believe that oxaplatin should have been a part of the treatment in both arms.